Specifically, changes that increase GBM cells' secretion of cytokines, such as transforming growth factor-β (TGF-β) and interleukin-10 (IL-10), promote immunosuppressive cell recruitment and cancer progression.17 By suppressing the activity of immune cells, GBM cells can proliferate without checks on their growth. The gene discussed is IL10; the disease is glioblastoma.